Your browser doesn't support javascript.
loading
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial.
Pettitt, Andrew R; Jackson, Richard; Cicconi, Silvia; Polydoros, Fotis; Yap, Christina; Dodd, James; Bickerstaff, Matthew; Stackpoole, Michael; Khan, Umair T; Carruthers, Stacey; Oates, Melanie; Lin, Ke; Coupland, Sarah E; Menon, Geetha; Kalakonda, Nagesh; McCarthy, Helen; Bloor, Adrian; Schuh, Anna; Duncombe, Andrew; Dearden, Claire; Fegan, Christopher; Kennedy, Ben; Walewska, Renata; Marshall, Scott; Fox, Christopher P; Hillmen, Peter.
Afiliación
  • Pettitt AR; University of Liverpool and Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Jackson R; University of Liverpool, Liverpool, UK.
  • Cicconi S; University of Liverpool, Liverpool, UK.
  • Polydoros F; University of Liverpool, Liverpool, UK.
  • Yap C; University of Birmingham, Birmingham, UK.
  • Dodd J; University of Liverpool, Liverpool, UK.
  • Bickerstaff M; University of Liverpool, Liverpool, UK.
  • Stackpoole M; University of Liverpool, Liverpool, UK.
  • Khan UT; University of Liverpool and Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK.
  • Carruthers S; University of Liverpool, Liverpool, UK.
  • Oates M; University of Liverpool, Liverpool, UK.
  • Lin K; Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • Coupland SE; Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • Menon G; Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • Kalakonda N; Univ of Liverpool and Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, UK.
  • McCarthy H; The Royal Bournemouth Hospital, Bournemouth, UK.
  • Bloor A; The Christie NHS Foundation Trust, Manchester, UK.
  • Schuh A; Churchill Hospital, Oxford, UK.
  • Duncombe A; Southampton General Hospital, Southampton, UK.
  • Dearden C; Royal Marsden NHS Foundation Trust, Sutton, UK.
  • Fegan C; University Hospital of Wales, Cardiff, UK.
  • Kennedy B; Leicester Royal Infirmary, Leicester, UK.
  • Walewska R; The Royal Bournemouth Hospital, Bournemouth, UK.
  • Marshall S; City Hospitals Sunderland NHS Trust, Sunderland, UK.
  • Fox CP; Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Hillmen P; University of Leeds, Leeds, UK.
Haematologica ; 105(12): 2868-2871, 2020 12 01.
Article en En | MEDLINE | ID: mdl-33256390
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Antineoplásicos Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Haematologica Año: 2020 Tipo del documento: Article País de afiliación: Reino Unido